VOL. 01 · 2026 · THE COVER ESSAY

Human Cloning,
explained.

An independent science journal covering cloning research, reproductive technology, stem-cell science, bioethics, and the future of genetic medicine — written for curious, careful readers.

No. 01 — The Cover Essay

What Is Human Cloning?

A careful, plain-English overview of what scientists actually mean by “cloning” — and what the headlines usually get wrong.

SCNT / Cells / DNA
The Reader

The simple definition, the three real categories, and the misconceptions worth unlearning.

Cloning is a single word for a family of very different techniques — from copying a piece of DNA in a lab dish to the still-hypothetical idea of producing a genetically identical human. This essay walks through each meaning and clarifies which are routine, which are research, and which are not happening at all.

No. 05 — Ethics Dossier

The questions every serious
cloning debate has to answer.

Cloning is not just a technical problem. It raises hard questions about identity, consent, family, and what societies owe to people who do not yet exist. Much of the public reaction is also driven by unease rather than evidence — a response that belongs less to biology than to the psychology of fear and phobia. Our bioethics coverage takes these questions seriously without taking a side.

Identity

If two people share DNA, do they share a self? Twin research suggests no — but the cultural anxiety is real.

Consent

A future person cannot consent to the conditions of their own creation. How do we weigh that?

Safety

Animal data show high rates of developmental problems. That alone shapes the law.

Family

Cloning blurs ordinary relationships — parent, sibling, donor — in ways law and culture have not settled.

Disability rights

Any selection technology raises uncomfortable questions about whose lives are valued.

Human dignity

Major declarations frame reproductive cloning as a dignity issue, not only a safety one.

Commercialisation

Markets for biological material can pressure the most vulnerable. Cloning would intensify that.

Inequality

If powerful technologies are accessible only to a few, they can deepen existing unfairness.

No. 06 — A Short Chronology

How we got here.

A timeline of the experiments and policy debates that shape today’s conversation — from frog embryos in the 1950s to current stem-cell research.

1952

Frog embryo transfer experiments

Robert Briggs and Thomas King demonstrate that the nucleus of an embryonic cell can direct development — the conceptual root of nuclear transfer.

1958 — 1962

Gurdon’s tadpoles

John Gurdon shows that nuclei from differentiated frog cells can be reprogrammed to produce tadpoles — a foundational result for the field.

1996

Dolly the sheep

Researchers in Scotland announce a sheep cloned from an adult somatic cell, forcing biology to revisit assumptions about cell identity.

1998

Human embryonic stem cells

James Thomson’s group derives the first human embryonic stem-cell lines, opening decades of regenerative-medicine research.

2005

UN Declaration on Human Cloning

Member states adopt a non-binding declaration calling on countries to prohibit forms of human cloning incompatible with human dignity.

2006 — 2007

Induced pluripotent stem cells

Shinya Yamanaka’s team reprograms adult cells into pluripotent stem cells, shifting much of regenerative-medicine research away from cloned embryos.

2013

Human somatic cell nuclear transfer

Researchers report deriving human embryonic stem-cell lines via somatic cell nuclear transfer — a research milestone, not a path to babies.

2018 — today

Primate cloning & the policy era

Cloned macaques in 2018 reignite debate. Most countries continue to prohibit reproductive cloning while permitting tightly regulated research.

No. 07 — Editorial Trust

What you can expect from this journal.

  • 01
    Independent. Not affiliated with any laboratory, fertility clinic, foundation, university, or advocacy group.
  • 02
    Source-led. Factual claims are checked against NIH, NHGRI, FDA, WHO, UNESCO, national academies and peer-reviewed literature.
  • 03
    Non-procedural. We explain concepts. We do not publish step-by-step methods, sourcing guidance, or clinical instructions.
  • 04
    Balanced. Where science, ethics, or law are unsettled, we say so — and we resist sensational claims in either direction.